The Prevalence of FOXP3+ Regulatory T-Cells in Peripheral Blood of Patients with NSCLC-Reference-Cited by-同舟云学术

The Prevalence of FOXP3+ Regulatory T-Cells in Peripheral Blood of Patients with NSCLC

Published:2009-06 Issue:3 Volume:24 Page:357-367
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Li Liu¹,Chao Qiu Guo¹,Ping Liu Zhong²,Xue Chen¹,Xia Zhao Yan¹,Qian Ding¹,Shi-ang Huang³

Affiliation:

1. Cancer Center, Union Hospital, Tongji Medical School, Hua-Zhong University of Science and Technology, Wuhan, People's of China.

2. Department of Hematology, Union Hospital, Tongji Medical School, Hua-Zhong University of Science and Technology, Wuhan, People's Republic of China.

3. Stem-Cell Center, Union Hospital, Tongji Medical School, Hua-Zhong University of Science and Technology, Wuhan, People's Republic of China.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2008.0612

Reference25 articles.

1. Cancer Statistics, 2008

2. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

3. Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

4. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

5. Regulatory T Cells

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating levels of FoxP3, M2 (sCD163) and IGF-1 as potential biomarkers associated with Laryngeal Squamous Cell Carcinoma in Tunisian patients;Journal of Immunoassay and Immunochemistry;2023-11-07

2. Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors;Journal of Hematology & Oncology;2022-07-07

4. A Meta-Analysis of Immune Checkpoint Inhibitors in the Treatment of Lung Cancer;Advances in Clinical Medicine;2022

5. Primary tumor and metastasis—sectioning the different steps of the metastatic cascade;Translational Lung Cancer Research;2020-10